Matteo et al.’s study suggests that the upregulation of SLC38A2 enhances glutamine-dependent resistance to oxidative stress and is correlated with worsened prognosis in triple-negative breast cancer (Morotti et al., 2021). This evidence concerns the gene SLC38A2 and triple-negative breast carcinoma.